Cadila Healthcare Limited Isosorbide Export Data — India (DGFT 2022–2026)

Name: Cadila Healthcare Limited Isosorbide Export Records India — #14 Exporter, 13 Shipments, $238.5K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Isosorbide

India Pharmaceutical Trade Intelligence

$44.9M181 Suppliers102 CountriesHS 30049099

ExportsIndia → UNITED STATES85.6%India → UNITED KINGDOM3.1%

ImportsUNITED STATES → India$345.3K GERMANY → India$186.9K

#1 Buyer: TORRENT PHARMA

Cadila Healthcare Limited — Isosorbide Exporter #14 | $238.5K Trade Value | TransData Nexus | TransData Nexus

Cadila Healthcare Limited — Isosorbide Exporter Profile

Indian Pharmaceutical Exporter · #14 for Isosorbide · $238.5K export value · DGFT Verified

Cadila Healthcare Limited is the #14 Indian exporter of Isosorbide with $238.5K in export value and 13 verified shipments. Cadila Healthcare Limited holds a 0.5% market share in Isosorbide exports across 4 countries. The company exports 41 pharmaceutical products worth $34.9M across 17 therapeutic categories.

Cadila Healthcare Limited — Isosorbide Export Profile: Buyers & Destinations

Cadila Healthcare Limited Isosorbide export treemap — buyers and destination countries | TransData Nexus

Where Does Cadila Healthcare Limited Export Isosorbide?

Country	Value	Shipments	Share
UNITED STATES	$92.7K	10	35.8%
SRI LANKA	$84.2K	2	32.5%
BRAZIL	$50.0K	1	19.3%
THAILAND	$31.9K	5

Who Are the Top Buyers of Isosorbide from Cadila Healthcare Limited?

Buyer	Country	Value	Orders
STATE PHARMACEUTICALS CORPORATION	SRI LANKA	$84.2K	2
ZYDUS NIKKHO FARMACEUTICA LIMITEDA	BRAZIL	$50.0K	1
EVERSANA LIFE SCIENCE SERVICES	UNITED STATES	$48.7K	4
KASPA PHARMACEUTICAL THAILAND	THAILAND	$26.2K	4
NORTHSTAR DISTRIBUTION CENTER	UNITED STATES	$22.2K	4
AMERISOURCE HEALTH SERVICES	UNITED STATES	$17.6K	1
KASPA PHARMACEUTICAL THAILAND CO LTD	THAILAND	$5.7K	1
NORTHSTAR DISTRIBUTION CENTER 8912	UNITED STATES	$4.1K	1

Cadila Healthcare Limited supplies Isosorbide to 8 buyers globally. The largest buyer is STATE PHARMACEUTICALS CORPORATION (SRI LANKA), followed by ZYDUS NIKKHO FARMACEUTICA LIMITEDA (BRAZIL) and EVERSANA LIFE SCIENCE SERVICES (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Isosorbide Formulations Does Cadila Healthcare Limited Export?

Product Description / Formulation	Value	Shipments
ISOSORBIDE MONONITRATE EX.RELEASE TABLETS USP 30MG ISOSORBIDE 12 X 10 T UNDERLUT NO.AD300323000664T DT.16.03.2023 VAL	$50.0K	1
ISOSORBIDE 20MG TAB 100S HOSP PAC ISOSORBIDE MONONITRATE 10 X 10 T QTY-85702.000 PAC-AS PER INV	$50.0K	1
ISOSORBIDE MONONITRATE EX.RELEASE TABLETS USP 30MG ISOSORBIDE 12X10 T	$34.2K	1
PHARMA MEDICINE FOR HUMAN USE-ISOSORBIDE DINITRATE TAB USP 10 MG-1X100-QTY-21000.000 PAC-AS PER INV	$22.6K	1
SOLOTRATE 20MG ISOSORBIDE MONONITRATE 2	$19.6K	3
ISOSORBIDE DINITRATE TABLETS USP 30MG [1	$17.6K	1
PHARMA MEDICINE FOR HUMAN USE-ISOSORBIDE DINITRATE TAB USP 30 MG-1X100-QTY-7488.000 PAC-AS PER INV	$12.7K	1
SOLOTRATE 20MG ISOSORBIDE MONONITRATE 20MG TABS 12X10	$12.3K	2
PHARMA MEDICINE FOR HUMAN USE-ISOSORBIDE DINITRATE TAB USP 40 MG - 1 X 100-QTY-2976.000 PAC-AS PER INV	$11.3K	1
ISOSORBIDE DINITRATE TABLETS USP 5MG [6144 PACK X 1X100 = 614400 NOS] BATCH NO.Z305146 & Z305147 MANUFACTURING . DT. 10/2023 EXP.D	$8.5K	1

Cadila Healthcare Limited exports 15 distinct Isosorbide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ISOSORBIDE MONONITRATE EX.RELEASE TABLETS USP 30MG ISOSORBID with 1 shipments worth $50.0K.

How Does Cadila Healthcare Limited Compare to Nearest Isosorbide Exporters?

Exporters ranked immediately above and below #14 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
12	MEDREICH LIMITED	$314.3K	35	1	$9.0K
13	MARKSANS PHARMA LIMITED	$246.3K	14	1	$17.6K
14	CADILA HEALTHCARE LIMITED ★	$238.5K	13	4	$18.3K
15	IND-SWIFT LIMITED	$150.0K	3	1	$50.0K

Cadila Healthcare Limited ranks #14 among 181 Indian Isosorbide exporters. Average shipment value of $18.3K compared to the market average of $164.5K. The closest competitors by value are MEDREICH LIMITED and MARKSANS PHARMA LIMITED.

Which Indian Ports Ship Isosorbide Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	412	21.0%
SAHAR AIR	308	15.7%
NHAVA SHEVA SEA (INNSA1)	168	8.6%
Bombay Air	92	4.7%
JNPT/ NHAVA SHEVA SEA	86	4.4%
DELHI AIR	74	3.8%
HYDERABAD ICD	64	3.3%
DELHI AIR CARGO ACC (INDEL4)	52	2.7%

Geopolitical & Trade Policy Impact on Cadila Healthcare Limited's Isosorbide Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Zydus. The escalating conflict in the Middle East has disrupted key maritime routes, particularly the Red Sea and Suez Canal, leading to longer transit times and increased freight costs. Major carriers have suspended or restricted transits, extending transit times by 10–20 days and raising freight rates by 40–50% on key India–Europe routes. (livemint.com) This situation poses significant challenges for time-sensitive pharmaceutical shipments, especially temperature-sensitive medicines. (economictimes.indiatimes.com)

Conversely, U.S.–China trade tensions have prompted the U.S. to impose tariffs on Chinese pharmaceutical imports, creating an opportunity for Indian exporters to fill the supply gap. However, the U.S. has also introduced tariffs on Indian imports, including a 25% "reciprocal" tariff, followed by an additional 25% penalty tied to India's continued imports of Russian oil, bringing the total duty to 50%. (en.wikipedia.org) While pharmaceuticals are currently exempt, the potential for future tariffs necessitates strategic planning.

In the European Union, compliance with the Falsified Medicines Directive (FMD) is crucial. The FMD mandates stringent serialization and traceability requirements to prevent counterfeit medicines from entering the supply chain. Non-compliance can result in restricted market access, making adherence to these regulations imperative for exporters like Zydus.

Cadila Healthcare Limited — Regulatory Compliance & Quality Standards

Maintaining compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. FDA, WHO, and EU Good Manufacturing Practice (GMP) guidelines set stringent quality benchmarks. Any lapses can lead to import alerts, product recalls, or facility shutdowns. For instance, in 2019, Zydus's Moraiya facility received an Official Action Indicated (OAI) classification from the U.S. FDA, indicating that regulatory and/or administrative actions were recommended. (moneycontrol.com) Such events underscore the importance of robust quality assurance systems.

The evolving regulatory landscape demands continuous investment in compliance infrastructure. The EU's Falsified Medicines Directive and the U.S. Drug Supply Chain Security Act (DSCSA) require advanced serialization and traceability measures. Non-compliance can result in restricted market access, making adherence to these regulations imperative for exporters like Zydus.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Isosorbide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Cadila Healthcare Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 18 individual customs records matching Cadila Healthcare Limited exporting Isosorbide, covering 15 formulations to 4 countries via 8 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 102+ countries, 537+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Isosorbide

Isosorbide

Cadila Healthcare Limited — Isosorbide Exporter Profile

Cadila Healthcare Limited — Isosorbide Export Profile: Buyers & Destinations

Where Does Cadila Healthcare Limited Export Isosorbide?

Who Are the Top Buyers of Isosorbide from Cadila Healthcare Limited?

What Is India's Total Isosorbide Export Value and How Much Does Cadila Healthcare Limited Contribute?

What Is the Average Shipment Value for Cadila Healthcare Limited's Isosorbide Exports?

How Does Cadila Healthcare Limited Compare to Other Indian Isosorbide Exporters?

What Isosorbide Formulations Does Cadila Healthcare Limited Export?

Regulatory Requirements: Exporting Isosorbide to Key Markets

United States — FDA

Brazil — ANVISA

How Does Cadila Healthcare Limited Compare to Nearest Isosorbide Exporters?

Which Indian Ports Ship Isosorbide Exports?

What Other Cardiovascular Products Does Cadila Healthcare Limited Export?

Geopolitical & Trade Policy Impact on Cadila Healthcare Limited's Isosorbide Exports

Cadila Healthcare Limited — Regulatory Compliance & Quality Standards

About Cadila Healthcare Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Isosorbide Export Data from Cadila Healthcare Limited

Isosorbide Stats

Company Overview

Top Products by Cadila Healthcare Limited

Related Analysis

Need Detailed Export Data?

Data Source